(Corrects quote attribution in paragraph 8 of September 14 story from Lynn Watkins, a U.S. Air Force veteran associated with ...

By Puyaan Singh and Kamal Choudhury Sept 14 (Reuters) - The U.S. FDA is holding a public hearing on Monday to gather feedback ...

Government agencies are increasingly expressing support for allowing greater access to psychedelic drugs such as psilocybin ...

Doctors, veterans and pharmacists testified on safety standards, access and provider training during a four-hour session in ...

Safety and access were top of mind at Monday’s public hearing exploring the regulation of psychedelic therapies. "The ...

Heading into an FDA hearing on Monday regarding the future of psychedelic treatments, public comments show wide support for ...

Sarit Hashkes, President of Filament Health Corp., will provide oral remarks at the United States Food and Drug ...

Elizabeth Richwine is at the frontier of a psychedelic boom that could transform medicine — and create a massive new industry ...

Rats given LSD, psilocybin or 2C-B showed three different brain patterns, and the psychedelic drugs still differed a week ...

SAN DIEGO, CA / ACCESS Newswire / / , Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company") a clinical-stage biotechnology company developing novel neuroplastogenic therapies beyond mood disorders, with an ...

UC San Francisco researchers are weighing in on one of the biggest challenges in psychedelic science, arguing that clinical trials need more convincing placebo treatments to better measure the drugs' ...

To learn more about the CNBC CFO Council, visit cnbccouncils.com/cfo Thursday's announcement that Eli Lilly will acquire AtaiBeckley, a clinical-stage maker of ...